Cargando…

Design, Synthesis, Computational, and Preclinical Evaluation of (nat)Ti/(45)Ti-Labeled Urea-Based Glutamate PSMA Ligand

Despite promising anti-cancer properties in vitro, all titanium-based pharmaceuticals have failed in vivo. Likewise, no target-specific positron emission tomography (PET) tracer based on the radionuclide (45)Ti has been developed, notwithstanding its excellent PET imaging properties. In this contrib...

Descripción completa

Detalles Bibliográficos
Autores principales:	Søborg Pedersen, Kristina, Baun, Christina, Michaelsen Nielsen, Karin, Thisgaard, Helge, Ingemann Jensen, Andreas, Zhuravlev, Fedor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7179113/ https://www.ncbi.nlm.nih.gov/pubmed/32131399 http://dx.doi.org/10.3390/molecules25051104

Ejemplares similares

Preclinical evaluation of [(58m)Co]Co-DOTA-PSMA-617 for Auger electron therapy of prostate cancer
por: Baun, Christina, et al.
Publicado: (2023)

GCP III is not the “off-target” for urea-based PSMA ligands
por: Lee, Zhenghong, et al.
Publicado: (2023)

Preclinical comparison of four [(18)F, (nat)Ga]rhPSMA-7 isomers: influence of the stereoconfiguration on pharmacokinetics
por: Wurzer, Alexander, et al.
Publicado: (2020)

Preclinical Evaluation of the Copper-64 Labeled GRPR-Antagonist RM26 in Comparison with the Cobalt-55 Labeled Counterpart for PET-Imaging of Prostate Cancer
por: Baun, Christina, et al.
Publicado: (2020)

Preclinical evaluation and first in human study of Al(18)F radiolabeled ODAP-urea-based PSMA targeting ligand for PET imaging of prostate cancer
por: Ren, Ya’nan, et al.
Publicado: (2022)

Properties of very hot nuclei formed in $^{64}$Zn + $^{nat}$Ti collisions at intermediate energies
por: Steckmeyer, J C, et al.
Publicado: (1995)

Formation and decay of hot nuclei in the $^{64}$Zn + $^{nat}$Ti and $^{36}$Ar + $^{27}$Al reactions
por: Steckmeyer, J C, et al.
Publicado: (1995)

A Preclinical Study of an (125)I-Labeled PSMA Ligand for Prostate-Cancer Puncture
por: Luan, Xiaohui, et al.
Publicado: (2022)

Formation and decay of hot nuclei in the $^{64}$Zn + $^{nat}$Ti and $^{36}$Ar + $^{27}$Al reactions at intermediate energies
por: Steckmeyer, J C, et al.
Publicado: (1995)

Synthesis and preclinical evaluation of DOTAGA-conjugated PSMA ligands for functional imaging and endoradiotherapy of prostate cancer
por: Weineisen, Martina, et al.
Publicado: (2014)

Synthesis and Preclinical Evaluation of (177)Lu-Labeled Radiohybrid PSMA Ligands for Endoradiotherapy of Prostate Cancer
por: Wurzer, Alexander, et al.
Publicado: (2022)

Synthesis of an Al(18)F radiofluorinated GLU-UREA-LYS(AHX)-HBED-CC PSMA ligand in an automated synthesis platform
por: Giglio, Javier, et al.
Publicado: (2018)

Monosodium Glutamate Reduces (68)Ga-PSMA-11 Uptake in Salivary Glands and Kidneys in a Preclinical Prostate Cancer Model
por: Rousseau, Etienne, et al.
Publicado: (2018)

Synthesis and preclinical evaluation of novel (18)F-labeled Glu-urea-Glu-based PSMA inhibitors for prostate cancer imaging: a comparison with (18)F-DCFPyl and (18)F-PSMA-1007
por: Robu, Stephanie, et al.
Publicado: (2018)

Synthesis, (123)I-Radiolabeling Optimization, and Initial Preclinical Evaluation of Novel Urea-Based PSMA Inhibitors with a Tributylstannyl Prosthetic Group in Their Structures
por: Hasnowo, Lutfi A., et al.
Publicado: (2023)

Preparation and Evaluation of [(18)F]AlF-NOTA-NOC for PET Imaging of Neuroendocrine Tumors: Comparison to [(68)Ga]Ga-DOTA/NOTA-NOC
por: Dam, Johan Hygum, et al.
Publicado: (2022)

Multi-curie production of gallium-68 on a biomedical cyclotron and automated radiolabelling of PSMA-11 and DOTATATE
por: Thisgaard, Helge, et al.
Publicado: (2021)

Fluorine-18 Labeled Urea-Based Ligands Targeting Prostate-Specific Membrane Antigen (PSMA) with Increased Tumor and Decreased Renal Uptake
por: Basuli, Falguni, et al.
Publicado: (2022)

Synthesis and preclinical evaluation of novel (99m)Tc-labeled PSMA ligands for radioguided surgery of prostate cancer
por: Kunert, Jan-Philip, et al.
Publicado: (2023)

Should Low Molecular Weight PSMA Targeted Ligands Get Bigger and Use Albumin Ligands for PSMA Targeting?
por: Huang, Steve S., et al.
Publicado: (2017)

Synthesis and in vitro and in vivo evaluation of urea-based PSMA inhibitors with increased lipophilicity
por: Wirtz, Martina, et al.
Publicado: (2018)

Preparation of Ti, Ti/TiC or Ti/TiN based hollow fibres with extremely low electrical resistivity
por: Jong, Ronald P. H., et al.
Publicado: (2020)

Bone response in vivo of Ti-45Zr alloy as dental implant material
por: Ou, Pinghua, et al.
Publicado: (2022)

Preclinical comparative study of [(18)F]AlF-PSMA-11 and [(18)F]PSMA-1007 in varying PSMA expressing tumors
por: Piron, Sarah, et al.
Publicado: (2022)

(44)Sc-PSMA-617 for radiotheragnostics in tandem with (177)Lu-PSMA-617—preclinical investigations in comparison with (68)Ga-PSMA-11 and (68)Ga-PSMA-617
por: Umbricht, Christoph A., et al.
Publicado: (2017)

Sublingual Atropine Administration as a Tool to Decrease Salivary Glands’ PSMA-Ligand Uptake: A Preclinical Proof of Concept Study Using [(68)Ga]Ga-PSMA-11
por: Nail, Vincent, et al.
Publicado: (2022)

With respect to Nat
Publicado: (1966)

Defective Black TiO(2): Effects of Annealing Atmospheres and Urea Addition on the Properties and Photocatalytic Activities
por: Zhang, Xu, et al.
Publicado: (2021)

Electronic Conduction in Ti/Poly-TiO(2)/Ti Structures
por: Hossein-Babaei, Faramarz, et al.
Publicado: (2016)

PSMA ligands for diagnosis and therapy of prostate cancer
por: Haberkorn, Uwe
Publicado: (2014)

Cross-sections for $^{45}Sc(p,2n)^{44}Ti$ and related reactions
por: Ejnisman, R, et al.
Publicado: (1996)

Processing and Microstructure of As-Cast Ti-45Al-2W-xC Alloys
por: Cegan, Tomas, et al.
Publicado: (2022)

Sonocatalytic degradation of EDTA in the presence of Ti and Ti@TiO(2) nanoparticles
por: El Hakim, Sara, et al.
Publicado: (2020)

Study on the Preparation of Network Ti-N/Ti Composites by Nitridation of Ti Powders
por: Xiu, Ziyang, et al.
Publicado: (2023)

Lys-urea-Aad, Lys-urea-Cmc and Lys-urea-Cms as potential pharmacophores for the design of PSMA-targeted radioligands to reduce off-target uptake in kidneys and salivary glands
por: Kuo, Hsiou-Ting, et al.
Publicado: (2023)

Urea-Assisted Synthesis of Mesoporous TiO(2) Photocatalysts for the Efficient Removal of Clofibric Acid from Water
por: Favier, Lidia, et al.
Publicado: (2021)

Studying polymorphic variants of the NAT2 gene (NAT2*5 and NAT2*7) in Nenets populations of Northern Siberia
por: Tiis, Roza Pavlovna, et al.
Publicado: (2020)

Study of correlation between the NAT2 phenotype and genotype status among Greenlandic Inuit
por: Birch Kristensen, Emilie, et al.
Publicado: (2018)

Synthesis and Preclinical Characterization of the PSMA-Targeted Hybrid Tracer PSMA-I&F for Nuclear and Fluorescence Imaging of Prostate Cancer
por: Schottelius, Margret, et al.
Publicado: (2019)

Separation of (44)Sc from (44)Ti in the Context of A Generator System for Radiopharmaceutical Purposes with the Example of [(44)Sc]Sc-PSMA-617 and [(44)Sc]Sc-PSMA-I&T Synthesis
por: Larenkov, Anton A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m469b4peb46kgcooj409fkj4kd